Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 AUD | 0.00% | 0.00% | +25.00% |
02-25 | Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
01-19 | Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
Sales 2022 | 446K 291K 398K | Sales 2023 | 149K 97.49K 133K | Capitalization | 13.88M 9.07M 12.38M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.31M -1.78M | Net income 2023 | -3M -1.96M -2.68M | EV / Sales 2022 | 37.7 x |
Net cash position 2022 | 6.34M 4.14M 5.66M | Net cash position 2023 | 2.99M 1.95M 2.67M | EV / Sales 2023 | 72.9 x |
P/E ratio 2022 |
-6.84
x | P/E ratio 2023 |
-4.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.93% |
Current month | +4.17% | ||
1 month | +7.14% | ||
3 months | +29.31% | ||
6 months | +13.64% | ||
Current year | +25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Grogan
CEO | Chief Executive Officer | - | 23-08-27 |
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sarah Driessens
LAW | General Counsel | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Andrew Guthrie
BRD | Director/Board Member | - | 21-04-25 |
Alex Ding
CHM | Chairman | - | 23-05-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.075 | 0.00% | 1,309 |
Delayed Quote Australian S.E., April 22, 2024 at 02:10 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.00% | 9.85M | |
+14.61% | 38.38B | |
-.--% | 11.15B | |
-7.28% | 7.3B | |
+7.47% | 6.87B | |
-3.91% | 5.91B | |
-10.44% | 5.6B | |
-6.14% | 5.54B | |
+31.35% | 5.19B | |
-13.45% | 4.58B |
- Stock Market
- Equities
- BGT Stock